F
Fifth Eye
Fifth Eye Enables Proactive Patient Care To Improve Outcomes, Avoid Adverse Events, Shorten Lengths Of Stay, And Reduce Costs
About Fifth Eye
Fifth Eye is a healthcare technology company specializing in real-time predictive analytics for hemodynamic instability, a condition where the blood flow is not stable. The company's core product is an advanced early warning system that helps medical professionals detect and respond to patient deterioration before it becomes critical. This technology is particularly valuable in intensive care units (ICUs) and emergency departments (EDs), where timely intervention can significantly improve patient outcomes and reduce mortality rates. Fifth Eye serves hospitals and healthcare providers, operating in the medical technology market. The business model is primarily subscription-based, where healthcare institutions pay for access to the predictive analytics platform. Revenue is generated through these subscriptions, as well as potential partnerships and licensing agreements. The company's technology leverages continuous monitoring and advanced algorithms to provide actionable insights, enabling proactive patient care. This not only helps in avoiding severe adverse events but also in shortening hospital stays and reducing overall healthcare costs.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jun 2025 | $0 | — | Airstrip Technologies | ↗ |
| SERIES A✓Equity / VC | Apr 2019 | $12M | $46M | Arboretum Ventures · Cultivation Capital | — |
Growth signals
Latest recorded traffic for Fifth Eye is 720 monthly website visits, up 63.6% over the last three months. Fifth Eye's team declined 28.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Invest Michigan
InvestMichigan
Western Michigan University
Series A2 investors entered at this stage
Arboretum Ventures
Cultivation Capital
Other known investors3 additional known investors
Airstrip Technologies
Stanford University
Biosciences Research and Commercialization Center
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Fifth Eye on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Fifth Eye’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






